Company intelligence / Profile preview
Venus Medicine Research Centre
- Ownership
- Private
- Development stage
- Commercial
Overview
Venus Medicine Research Centre (VMRC) is the R&D arm of Venus Remedies Limited, focused on developing innovative solutions in antimicrobial resistance, oncology, wound care, and pain management. It leverages advanced technologies like nanotechnology and has a pipeline spanning preclinical to approved products, including an FDA QIDP-designated anti-infective.
- Therapeutic areas
- OncologyHematologyNeurologyInfectious Diseases
- Modalities
- Small moleculeHerbal medicineNanoparticle (nanocarrier drug delivery)Biologics
- Industry
- Biotech
Drug pipeline
9 assets8 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Venus Medicine Research Centre.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Venus Medicine Research Centre.